FGFR1 and neoplasm: Patient’s breast tumour, bone metastasis and PDX showed amplification of FGFR1 and CCND1 and bone metastasis and PDX carry a homozygous deletion of CDKN2A. In this tumour, inhibition of PLK1 and CDK4/6 did not arrest tumour growth.